1980 related articles for article (PubMed ID: 27177019)
1. RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury.
Newton K; Dugger DL; Maltzman A; Greve JM; Hedehus M; Martin-McNulty B; Carano RA; Cao TC; van Bruggen N; Bernstein L; Lee WP; Wu X; DeVoss J; Zhang J; Jeet S; Peng I; McKenzie BS; Roose-Girma M; Caplazi P; Diehl L; Webster JD; Vucic D
Cell Death Differ; 2016 Sep; 23(9):1565-76. PubMed ID: 27177019
[TBL] [Abstract][Full Text] [Related]
2. RIPK1 inhibits ZBP1-driven necroptosis during development.
Newton K; Wickliffe KE; Maltzman A; Dugger DL; Strasser A; Pham VC; Lill JR; Roose-Girma M; Warming S; Solon M; Ngu H; Webster JD; Dixit VM
Nature; 2016 Dec; 540(7631):129-133. PubMed ID: 27819682
[TBL] [Abstract][Full Text] [Related]
3. RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation.
Lin J; Kumari S; Kim C; Van TM; Wachsmuth L; Polykratis A; Pasparakis M
Nature; 2016 Dec; 540(7631):124-128. PubMed ID: 27819681
[TBL] [Abstract][Full Text] [Related]
4. RIPK3-MLKL-mediated necroinflammation contributes to AKI progression to CKD.
Chen H; Fang Y; Wu J; Chen H; Zou Z; Zhang X; Shao J; Xu Y
Cell Death Dis; 2018 Aug; 9(9):878. PubMed ID: 30158627
[TBL] [Abstract][Full Text] [Related]
5. The neurotoxicant PCB-95 by increasing the neuronal transcriptional repressor REST down-regulates caspase-8 and increases Ripk1, Ripk3 and MLKL expression determining necroptotic neuronal death.
Guida N; Laudati G; Serani A; Mascolo L; Molinaro P; Montuori P; Di Renzo G; Canzoniero LMT; Formisano L
Biochem Pharmacol; 2017 Oct; 142():229-241. PubMed ID: 28676433
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of RIPK1 Markedly Exacerbates Murine Immune-Mediated Liver Injury through Massive Apoptosis of Hepatocytes, Independent of Necroptosis and Inhibition of NF-κB.
Suda J; Dara L; Yang L; Aghajan M; Song Y; Kaplowitz N; Liu ZX
J Immunol; 2016 Oct; 197(8):3120-3129. PubMed ID: 27605011
[TBL] [Abstract][Full Text] [Related]
7. FKBP12 mediates necroptosis by initiating RIPK1-RIPK3-MLKL signal transduction in response to TNF receptor 1 ligation.
Wang Z; Feng J; Yu J; Chen G
J Cell Sci; 2019 May; 132(10):. PubMed ID: 31028177
[TBL] [Abstract][Full Text] [Related]
8. Phenytoin inhibits necroptosis.
von Mässenhausen A; Tonnus W; Himmerkus N; Parmentier S; Saleh D; Rodriguez D; Ousingsawat J; Ang RL; Weinberg JM; Sanz AB; Ortiz A; Zierleyn A; Becker JU; Baratte B; Desban N; Bach S; Schiessl IM; Nogusa S; Balachandran S; Anders HJ; Ting AT; Bleich M; Degterev A; Kunzelmann K; Bornstein SR; Green DR; Hugo C; Linkermann A
Cell Death Dis; 2018 Mar; 9(3):359. PubMed ID: 29500402
[TBL] [Abstract][Full Text] [Related]
9. RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis.
Rickard JA; O'Donnell JA; Evans JM; Lalaoui N; Poh AR; Rogers T; Vince JE; Lawlor KE; Ninnis RL; Anderton H; Hall C; Spall SK; Phesse TJ; Abud HE; Cengia LH; Corbin J; Mifsud S; Di Rago L; Metcalf D; Ernst M; Dewson G; Roberts AW; Alexander WS; Murphy JM; Ekert PG; Masters SL; Vaux DL; Croker BA; Gerlic M; Silke J
Cell; 2014 May; 157(5):1175-88. PubMed ID: 24813849
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosis.
Mulay SR; Desai J; Kumar SV; Eberhard JN; Thomasova D; Romoli S; Grigorescu M; Kulkarni OP; Popper B; Vielhauer V; Zuchtriegel G; Reichel C; Bräsen JH; Romagnani P; Bilyy R; Munoz LE; Herrmann M; Liapis H; Krautwald S; Linkermann A; Anders HJ
Nat Commun; 2016 Jan; 7():10274. PubMed ID: 26817517
[TBL] [Abstract][Full Text] [Related]
11. A cytosolic heat shock protein 90 and co-chaperone p23 complex activates RIPK3/MLKL during necroptosis of endothelial cells in acute respiratory distress syndrome.
Yu X; Mao M; Liu X; Shen T; Li T; Yu H; Zhang J; Chen X; Zhao X; Zhu D
J Mol Med (Berl); 2020 Apr; 98(4):569-583. PubMed ID: 32072232
[TBL] [Abstract][Full Text] [Related]
12. Ligustroflavone reduces necroptosis in rat brain after ischemic stroke through targeting RIPK1/RIPK3/MLKL pathway.
Zhang YY; Liu WN; Li YQ; Zhang XJ; Yang J; Luo XJ; Peng J
Naunyn Schmiedebergs Arch Pharmacol; 2019 Sep; 392(9):1085-1095. PubMed ID: 31055628
[TBL] [Abstract][Full Text] [Related]
13. Celastrol inhibits necroptosis by attenuating the RIPK1/RIPK3/MLKL pathway and confers protection against acute pancreatitis in mice.
Liang QQ; Shi ZJ; Yuan T; Chen SY; Li YP; Zhang HR; You YP; Xu R; Xu LH; Hu B; Ouyang DY; Zha QB; He XH
Int Immunopharmacol; 2023 Apr; 117():109974. PubMed ID: 37012867
[TBL] [Abstract][Full Text] [Related]
14. A pan-RAF inhibitor LY3009120 inhibits necroptosis by preventing phosphorylation of RIPK1 and alleviates dextran sulfate sodium-induced colitis.
Zhang C; Luo Y; He Q; Liu S; He A; Yan J
Clin Sci (Lond); 2019 Apr; 133(8):919-932. PubMed ID: 30944150
[TBL] [Abstract][Full Text] [Related]
15. Zinc finger protein 91 mediates necroptosis by initiating RIPK1-RIPK3-MLKL signal transduction in response to TNF receptor 1 ligation.
Zhong Y; Zhang ZH; Wang JY; Xing Y; Ri MH; Jin HL; Zuo HX; Li MY; Ma J; Jin X
Toxicol Lett; 2022 Mar; 356():75-88. PubMed ID: 34942311
[TBL] [Abstract][Full Text] [Related]
16. Receptor-Interacting Serine/Threonine-Protein Kinase 3 (RIPK3)-Mixed Lineage Kinase Domain-Like Protein (MLKL)-Mediated Necroptosis Contributes to Ischemia-Reperfusion Injury of Steatotic Livers.
Ni HM; Chao X; Kaseff J; Deng F; Wang S; Shi YH; Li T; Ding WX; Jaeschke H
Am J Pathol; 2019 Jul; 189(7):1363-1374. PubMed ID: 31026418
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease.
Majdi A; Aoudjehane L; Ratziu V; Islam T; Afonso MB; Conti F; Mestiri T; Lagouge M; Foufelle F; Ballenghien F; Ledent T; Moldes M; Cadoret A; Fouassier L; Delaunay JL; Aït-Slimane T; Courtois G; Fève B; Scatton O; Prip-Buus C; Rodrigues CMP; Housset C; Gautheron J
J Hepatol; 2020 Apr; 72(4):627-635. PubMed ID: 31760070
[TBL] [Abstract][Full Text] [Related]
18. RIPK1 ensures intestinal homeostasis by protecting the epithelium against apoptosis.
Takahashi N; Vereecke L; Bertrand MJ; Duprez L; Berger SB; Divert T; Gonçalves A; Sze M; Gilbert B; Kourula S; Goossens V; Lefebvre S; Günther C; Becker C; Bertin J; Gough PJ; Declercq W; van Loo G; Vandenabeele P
Nature; 2014 Sep; 513(7516):95-9. PubMed ID: 25186904
[TBL] [Abstract][Full Text] [Related]
19. RIPK3 collaborates with GSDMD to drive tissue injury in lethal polymicrobial sepsis.
Chen H; Li Y; Wu J; Li G; Tao X; Lai K; Yuan Y; Zhang X; Zou Z; Xu Y
Cell Death Differ; 2020 Sep; 27(9):2568-2585. PubMed ID: 32152555
[TBL] [Abstract][Full Text] [Related]
20. Sorafenib tosylate inhibits directly necrosome complex formation and protects in mouse models of inflammation and tissue injury.
Martens S; Jeong M; Tonnus W; Feldmann F; Hofmans S; Goossens V; Takahashi N; Bräsen JH; Lee EW; Van der Veken P; Joossens J; Augustyns K; Fulda S; Linkermann A; Song J; Vandenabeele P
Cell Death Dis; 2017 Jun; 8(6):e2904. PubMed ID: 28661484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
